Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease | Zendy

Kiyotaka Kugiyama | Zendy; Hideki Doi | Zendy; Keiji Takazoe | Zendy; Hiroaki Kawano | Zendy; Hirofumi Soejima | Zendy; Yuji Mizuno | Zendy; Ryusuke Tsunoda | Zendy; Tomohiro Sakamoto | Zendy; Takamitsu Nakano | Zendy; Katsuyuki Nakajima | Zendy; Hisao Ogawa | Zendy; Seigo Sugiyama | Zendy; Michihiro Yoshimura | Zendy; Hirofumi Yasue | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Author(s) -

Kiyotaka Kugiyama,

Hideki Doi,

Keiji Takazoe,

Hiroaki Kawano,

Hirofumi Soejima,

Yuji Mizuno,

Ryusuke Tsunoda,

Tomohiro Sakamoto,

Takamitsu Nakano,

Katsuyuki Nakajima,

Hisao Ogawa,

Seigo Sugiyama,

Michihiro Yoshimura,

Hirofumi Yasue

Publication year - 1999

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.99.22.2858

Subject(s) - medicine , hypertriglyceridemia , cardiology , myocardial infarction , coronary artery disease , diabetes mellitus , apolipoprotein b , hazard ratio , lipoprotein , cholesterol , angina , triglyceride , endocrinology , confidence interval

Remnant lipoproteins are atherogenic, but assays of remnants have not been available in routine clinical laboratories because of the lack of practical and validated methods. A simple and reliable method for such an assay, using an immunochemical approach, has recently been developed. This study prospectively examined whether remnant lipoprotein levels in fasting serum, measured by our method, may have prognostic value in patients with coronary artery disease (CAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research